Back to Search
PETER JASINSKI, PHARMD
PHARMD
Pharmacist
NPI: 1457640070Individual
Specialties, Licenses & Credentials
Research & Publications (6)
Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo.
PMID 19010291·Transl Res·2008
7-preclinical
Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.
PMID 18448327·Eur J Cancer·2008
8-other
A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.
PMID 17957339·Invest New Drugs·2008
7-preclinical
Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone.
PMID 18723339·Eur J Cancer·2008
7-preclinical
Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.
PMID 17805485·Invest New Drugs·2008
7-preclinical
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy.
PMID 17653078·Br J Cancer·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 7 E SILVER ST
WESTFIELD, MA 01085 - Phone
- (413) 568-5116
Quick Facts
- NPI
- 1457640070
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile